Highlights Teva Pharmaceutical Industries Ltd (ADR) Nasdaq

Equities

US8816242098

Highlights

Unlock all the news: Be the first to know and act before the market!

Sector Update: Health Care Stocks Retreat Late Afternoon	02/07	MT
Sector Update: Health Care Stocks Slipping in Afternoon Trading	01/07	MT
Teva Pharmaceuticals Faces FTC Probe on Patent Listings	01/07	MT
Correction: Top Midday Stories: Boeing to Acquire Spirit AeroSystems; Robinhood Acquires Pluto; FTC Probes Teva; BlackRock Acquires Preqin; SCOTUS Grants Trump Some Immunity	01/07	MT
Top Midday Stories: Boeing to Acquire Spirit AeroSystems; Robinhood Acquires Pluto; FTC Probes Teva; BlackRock Acquires Preqin; SCOTUS Grants Trump Some Immunity	01/07	MT
Teva Pharmaceuticals Faces FTC Probe on Patent Listings	01/07	MT
Teva Pharmaceuticals Faces FTC Probe on Patent Listings	01/07	MT
FTC Opens Investigation Into Teva Pharmaceuticals	01/07	MT
Vanda Pharmaceuticals Says Federal Court Allows Patent Lawsuit Over Hetlioz	01/07	MT
Teva Pharmaceutical Industries Ltd Announces New AJOVY® (Fremanezumab) Migraine Prevention Data Challenges Treatment Pauses	28/06	CI
Global markets live: UBS, Boeing, AT&T, Rivian, Nvidia, Tesla...	25/06
Teva Pharmaceutical Pays $750 Million to Resolve Tax-Related Litigation	25/06	MT
Teva settles tax dispute in Israel with $750 mln payment	25/06	RE
Teva Pharmaceutical Industries Limited Announces Launch of Authorized Generic of Victoza® (Liraglutide Injection 1.8Mg), in the United States	24/06	CI
Global markets live: Tesco, Adobe, Tyson Foods, GameStop, Teva...	14/06
Teva Pharmaceutical Sues Corcept Therapeutics Alleging Market Monopolization for Cushing's Syndrome Drug Korlym	14/06	MT
Teva Pharmaceutical Industries Limited Announces AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets Now U.S. FDA Approved as a One Pill, Once-Daily Treatment Option for Clinically Therapeutic Doses (24?48 mg/day)	30/05	CI
Teva Pharmaceutical Industries Limited and Alvotech Announce SIMLANDI® Injection Now Available in the U.S	21/05	CI
Sector Update: Health Care Stocks Slipping Wednesday Afternoon	08/05	MT
Teva Pharmaceutical Shares Rise After Reporting Higher Q1 Earnings, Revenue; 2024 Guidance Reaffirmed	08/05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Teva Pharmaceutical Industries isn't out of the woods yet

February 01, 2024 at 03:11 pm IST

INTERVIEW - Richard Francis, CEO of Teva Pharmaceutical: solid quarter, full-year forecasts raised

August 03, 2023 at 12:49 am IST